HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Influenza-pseudotyped Gag virus-like particle vaccines provide broad protection against highly pathogenic avian influenza challenge.

Abstract
Influenza-pseudotyped Gag virus-like particles (VLPs) were produced via the expression of influenza hemagglutinin (HA), neuraminidase (NA) and the murine leukemia virus Gag product in the baculovirus-insect cell expression system. Hemagglutination specific activities of sucrose gradient-purified VLPs were similar to those of egg-grown influenza viruses but particle morphologies were gamma retrovirus-like in the form of consistent 100nm spheres. Immunization of mice and ferrets demonstrated robust immunogenicity and protection from challenge with no measurable morbidity. Ferret data were striking in that immunization with H5N1 VLPs representing either A/Vietnam/1203/04 or A/Indonesia/5/05 resulted in solid protection against highly pathogenic A/Vietnam/1203/04 challenge with no detectable virus in the upper respiratory tract post-challenge in either group. H1N1 VLP immunization of ferrets resulted in partial protection against H5N1 challenge with markedly accelerated virus clearance from the upper respiratory tract relative to controls. The immunogenicity of influenza-pseudotyped VLPs was not dependent on the adjuvant properties of replication competent contaminating baculovirus. These data demonstrate robust vaccine protection of Gag-based, influenza-pseudotyped VLPs carrying a variety of influenza antigens and suggest applicability toward a number of additional respiratory viruses.
AuthorsJoel R Haynes, Leslie Dokken, James A Wiley, Andrew G Cawthon, John Bigger, Allen G Harmsen, Charles Richardson
JournalVaccine (Vaccine) Vol. 27 Issue 4 Pg. 530-41 (Jan 22 2009) ISSN: 0264-410X [Print] Netherlands
PMID19026705 (Publication Type: Journal Article, Research Support, U.S. Gov't, Non-P.H.S.)
Chemical References
  • Gene Products, gag
  • Hemagglutinin Glycoproteins, Influenza Virus
  • Influenza Vaccines
  • Neuraminidase
Topics
  • Animals
  • Baculoviridae (immunology)
  • Cells, Cultured
  • Female
  • Ferrets (immunology)
  • Gene Products, gag (administration & dosage, immunology)
  • Hemagglutinin Glycoproteins, Influenza Virus (immunology, isolation & purification)
  • Influenza A Virus, H1N1 Subtype (immunology)
  • Influenza A Virus, H5N1 Subtype (immunology)
  • Influenza Vaccines (immunology)
  • Male
  • Mice
  • Mice, Inbred BALB C
  • Neuraminidase (immunology)
  • Orthomyxoviridae Infections (immunology, prevention & control)
  • Time Factors
  • Virion (immunology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: